Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

OBJECTIVE: To examine the risk of serious infection conveyed by tumour necrosis factor α (TNFα) inhibitors in the treatment of rheumatoid arthritis (RA). METHODS: Data from patients with RA enrolled in the German biologics register RABBIT were used for analysis. Baseline patient characteristics, tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Strangfeld, A, Eveslage, M, Schneider, M, Bergerhausen, H J, Klopsch, T, Zink, A, Listing, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184240/
https://www.ncbi.nlm.nih.gov/pubmed/21791449
http://dx.doi.org/10.1136/ard.2011.151043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184240/
https://www.ncbi.nlm.nih.gov/pubmed/21791449
http://dx.doi.org/10.1136/ard.2011.151043

Ejemplares similares